System updates will be applied on February 19, 2026 at 6:00 PM. These updates will include changes to the user interface. Work is expected to take approximately 30 minutes to complete, during which the site will be unavailable.

	Amend SB 1143 (House Committee Report) as follows:                           
	(1)  On page 3, between line 18 and line 19, insert new 
SECTION 3, as follows:
	SECTION 3.  Chapter 32, Insurance Code, is amended by adding 
new Section 32.0221, to read as follows:
	Sec. 32.0221.  TEXAS HEALTH BENEFITS STUDY.  (a)  The 
department shall study the disparity in patient co-payments between 
orally- and intravenously-administered chemotherapies, the reasons 
for the disparity, and the patient benefits in establishing 
co-payment parity between oral and infused chemotherapy agents.
	(b)  Not later than August 1, 2010, the department shall 
submit to the governor, the lieutenant governor, the speaker of the 
house of representatives, and the appropriate standing committees 
of the legislature a report regarding the results of the study 
conducted under Subsection (a), together with any recommendation 
for legislation.
	(2)  On page 3, line 19, between "by" and "this", insert 
"SECTION 1 and SECTION 2 of".
	(3)  Renumber the remaining sections of the bill as 
appropriate.